This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Australian housing supply under scrutiny in Stockland-Lendlease deal review

By Ryan Cropp ( February 9, 2024, 05:10 GMT | Insight) -- Stockland Corporation and Supalai Australia’s A$1.06 billion ($688 million) joint bid for the development rights of 12 major residential property projects owned by rival developer Lendlease has attracted the scrutiny of the country’s competition watchdog. In a market inquiries letter issued this week, the Australian Competition & Consumer Commission said it would focus its investigation on whether the Stockland-Supalai joint venture would have the ability and the incentive to reduce the supply of residential housing in key growth corridors in several Australian cities.Stockland Corporation and Supalai Australia’s A$1.06 billion ($688 million) joint bid for the development rights of 12 major residential property projects owned by rival developer Lendlease has attracted the scrutiny of the country’s competition watchdog....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login